We are increasing our annual revenue guidance to the range of $182 million to $186 million. We are also adjusting our gross margin guidance for the full year to be in the range of 74% to 76%. Additionally, we reiterate that we expect to be net cash flow positive cumulatively for the period from April 1st through year end.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXGN:
- AxoGen Updates Corporate Presentation for Stakeholders
- Axogen, Inc. Announces New Leadership Appointments
- Is AXGN a Buy, Before Earnings?
- Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
- AxoGen reports inducement grants under Nasdaq listing rule
Questions or Comments about the article? Write to editor@tipranks.com